JPRN-jRCTs071180059CompletedPhase 4
Multicenter Apixaban theRapy for VEnous thromboemboLism and evaluation by Total Thrombus-formation Analysis System study - MARVEL-TTAS
Tsujita Kenichi0 sites20 target enrollmentStarted: March 19, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
The purpose was to determine the appropriate effect of antithrombotic drugs using a new thrombogenicity assessment system (T-TAS) for pulmonary thromboembolism and deep vein thrombosis. However, the target number of cases was not reached, and analysis including the primary endpoint was difficult. The combination of the start of study enrollment and the outbreak of COVID-19 was a factor that made enrollment difficult.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •New onset case of venous thromboembolism and deep vein thrombosis, who requires permanent antithrombotic therapy
Exclusion Criteria
- •1. contraindication of apixaban usage
- •2. Patients who are already taking antithrombotic or thrombolytic therapies
- •3. Patients who are judged as an inappropriate case to enroll
Investigators
Similar Trials
Completed
Phase 4
Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid SyndromeThrombosisAntiphospholipid SyndromeNCT02295475Scott C. Woller, MD48
Completed
Phase 4
Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP StudyNeoplasmsVenous ThrombosisNCT02581176University Hospital, Akershus300
Completed
Phase 2
Oral Anticoagulant Apixaban for Treatment of Venous ThromboembolismVenous ThromboembolismNCT04041843New York Medical College25
Completed
Phase 4
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial FibrillationAtrial FibrillationStrokeNCT01938248Population Health Research Institute4,012
Completed
Phase 3
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryDeep Vein ThrombosisPulmonary EmbolismNCT00452530Bristol-Myers Squibb3,221